Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Responds to CMS Proposed Rule for CY 2022 PFS and Other Policy Changes (NCD 180.2)
-
Group Sign-On Letter Supporting the VITAL Act
-
ACMG Letter to Congress about Medicaid Coverage of Genetic and Genomic Testing
-
ACMG Letter to Congress Concerning the Verifying Accurate Leading-edge IVCT Development (VALID) Act
-
ACMG Comments to CMS about Proposed Changes to the PFS for CY 2021
-
Group Sign-on Letter to HHS Supporting Clarification of LDT Regulatory Process
-
ACMG Letter to CMS Requesting Reconsideration of Payment Determination for a PALB2 CPT Code 81307
-
ACMG Comments to CMS Regarding CY 2020 CLFS Preliminary Payment Determinations
-
ACMG-ASHG Joint Congressional Briefing on the Undiagnosed Diseases Network
-
ACMG Comments to Congress Concerning the Verifying Accurate Leading-edge IVCT Development (VALID) Act Discussion Draft